NDC 71335-2973 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-2973

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA209389
Marketed since
June 19, 2025
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (6)

Package NDCDescriptionSince
71335-2973-190 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-1)Nov 6, 2025
71335-2973-260 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-2)Nov 6, 2025
71335-2973-330 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-3)Nov 6, 2025
71335-2973-414 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-4)Nov 6, 2025
71335-2973-512 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-5)Nov 6, 2025
71335-2973-610 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-6)Nov 6, 2025

Other Ondansetron products